The global market for Parkinson's Disease Treatments was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Parkinson’s disease is a central nervous system syndrome which affects the motor neuron, mainly characterized by rigidity, tremor, depression, dementia, and so on. Treatment for this disease is mostly symptomatic and almost no curative treatment alternatives are available.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease Treatments, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease Treatments.

The Parkinson's Disease Treatments market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parkinson's Disease Treatments market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Parkinson's Disease Treatments companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Parkinson's Disease Treatments Market Report

Report Metric	Details
Report Name	Parkinson's Disease Treatments Market
CAGR	5%
Segment by Type	Dopamine Agonists Levodopa Glutamate Antagonist Apomorphine COMT Inhibitors Anticholinergics MAO-B Inhibitors Other Drugs
Segment by Application	Hospitals Healthcare Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Merck, Novartis, Teva, Boehringer Ingelheim, Impax, Abbvie, Bausch Health, Lundbeck, Sun Pharma, Wockhardt, Acadia, UCB
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson's Disease Treatments company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Parkinson's Disease Treatments Market report?

Ans: The main players in the Parkinson's Disease Treatments Market are GSK, Merck, Novartis, Teva, Boehringer Ingelheim, Impax, Abbvie, Bausch Health, Lundbeck, Sun Pharma, Wockhardt, Acadia, UCB

What are the Application segmentation covered in the Parkinson's Disease Treatments Market report?

Ans: The Applications covered in the Parkinson's Disease Treatments Market report are Hospitals, Healthcare Institutes, Others

What are the Type segmentation covered in the Parkinson's Disease Treatments Market report?

Ans: The Types covered in the Parkinson's Disease Treatments Market report are Dopamine Agonists, Levodopa, Glutamate Antagonist, Apomorphine, COMT Inhibitors Anticholinergics, MAO-B Inhibitors, Other Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Parkinson's Disease Treatments Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Dopamine Agonists

1.2.3 Levodopa

1.2.4 Glutamate Antagonist

1.2.5 Apomorphine

1.2.6 COMT Inhibitors Anticholinergics

1.2.7 MAO-B Inhibitors

1.2.8 Other Drugs

1.3 Market by Application

1.3.1 Global Parkinson's Disease Treatments Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Healthcare Institutes

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Parkinson's Disease Treatments Market Perspective (2020-2031)

2.2 Global Parkinson's Disease Treatments Growth Trends by Region

2.2.1 Global Parkinson's Disease Treatments Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Parkinson's Disease Treatments Historic Market Size by Region (2020-2025)

2.2.3 Parkinson's Disease Treatments Forecasted Market Size by Region (2026-2031)

2.3 Parkinson's Disease Treatments Market Dynamics

2.3.1 Parkinson's Disease Treatments Industry Trends

2.3.2 Parkinson's Disease Treatments Market Drivers

2.3.3 Parkinson's Disease Treatments Market Challenges

2.3.4 Parkinson's Disease Treatments Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Parkinson's Disease Treatments Players by Revenue

3.1.1 Global Top Parkinson's Disease Treatments Players by Revenue (2020-2025)

3.1.2 Global Parkinson's Disease Treatments Revenue Market Share by Players (2020-2025)

3.2 Global Parkinson's Disease Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Parkinson's Disease Treatments Revenue

3.4 Global Parkinson's Disease Treatments Market Concentration Ratio

3.4.1 Global Parkinson's Disease Treatments Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Treatments Revenue in 2024

3.5 Global Key Players of Parkinson's Disease Treatments Head office and Area Served

3.6 Global Key Players of Parkinson's Disease Treatments, Product and Application

3.7 Global Key Players of Parkinson's Disease Treatments, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Parkinson's Disease Treatments Breakdown Data by Type

4.1 Global Parkinson's Disease Treatments Historic Market Size by Type (2020-2025)

4.2 Global Parkinson's Disease Treatments Forecasted Market Size by Type (2026-2031)

5 Parkinson's Disease Treatments Breakdown Data by Application

5.1 Global Parkinson's Disease Treatments Historic Market Size by Application (2020-2025)

5.2 Global Parkinson's Disease Treatments Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Parkinson's Disease Treatments Market Size (2020-2031)

6.2 North America Parkinson's Disease Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Parkinson's Disease Treatments Market Size by Country (2020-2025)

6.4 North America Parkinson's Disease Treatments Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Parkinson's Disease Treatments Market Size (2020-2031)

7.2 Europe Parkinson's Disease Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Parkinson's Disease Treatments Market Size by Country (2020-2025)

7.4 Europe Parkinson's Disease Treatments Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Parkinson's Disease Treatments Market Size (2020-2031)

8.2 Asia-Pacific Parkinson's Disease Treatments Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2020-2025)

8.4 Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Parkinson's Disease Treatments Market Size (2020-2031)

9.2 Latin America Parkinson's Disease Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Parkinson's Disease Treatments Market Size by Country (2020-2025)

9.4 Latin America Parkinson's Disease Treatments Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Parkinson's Disease Treatments Market Size (2020-2031)

10.2 Middle East & Africa Parkinson's Disease Treatments Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2020-2025)

10.4 Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Parkinson's Disease Treatments Introduction

11.1.4 GSK Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.1.5 GSK Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Parkinson's Disease Treatments Introduction

11.2.4 Merck Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Parkinson's Disease Treatments Introduction

11.3.4 Novartis Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Teva

11.4.1 Teva Company Details

11.4.2 Teva Business Overview

11.4.3 Teva Parkinson's Disease Treatments Introduction

11.4.4 Teva Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.4.5 Teva Recent Development

11.5 Boehringer Ingelheim

11.5.1 Boehringer Ingelheim Company Details

11.5.2 Boehringer Ingelheim Business Overview

11.5.3 Boehringer Ingelheim Parkinson's Disease Treatments Introduction

11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.5.5 Boehringer Ingelheim Recent Development

11.6 Impax

11.6.1 Impax Company Details

11.6.2 Impax Business Overview

11.6.3 Impax Parkinson's Disease Treatments Introduction

11.6.4 Impax Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.6.5 Impax Recent Development

11.7 Abbvie

11.7.1 Abbvie Company Details

11.7.2 Abbvie Business Overview

11.7.3 Abbvie Parkinson's Disease Treatments Introduction

11.7.4 Abbvie Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.7.5 Abbvie Recent Development

11.8 Bausch Health

11.8.1 Bausch Health Company Details

11.8.2 Bausch Health Business Overview

11.8.3 Bausch Health Parkinson's Disease Treatments Introduction

11.8.4 Bausch Health Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.8.5 Bausch Health Recent Development

11.9 Lundbeck

11.9.1 Lundbeck Company Details

11.9.2 Lundbeck Business Overview

11.9.3 Lundbeck Parkinson's Disease Treatments Introduction

11.9.4 Lundbeck Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.9.5 Lundbeck Recent Development

11.10 Sun Pharma

11.10.1 Sun Pharma Company Details

11.10.2 Sun Pharma Business Overview

11.10.3 Sun Pharma Parkinson's Disease Treatments Introduction

11.10.4 Sun Pharma Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.10.5 Sun Pharma Recent Development

11.11 Wockhardt

11.11.1 Wockhardt Company Details

11.11.2 Wockhardt Business Overview

11.11.3 Wockhardt Parkinson's Disease Treatments Introduction

11.11.4 Wockhardt Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.11.5 Wockhardt Recent Development

11.12 Acadia

11.12.1 Acadia Company Details

11.12.2 Acadia Business Overview

11.12.3 Acadia Parkinson's Disease Treatments Introduction

11.12.4 Acadia Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.12.5 Acadia Recent Development

11.13 UCB

11.13.1 UCB Company Details

11.13.2 UCB Business Overview

11.13.3 UCB Parkinson's Disease Treatments Introduction

11.13.4 UCB Revenue in Parkinson's Disease Treatments Business (2020-2025)

11.13.5 UCB Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Parkinson's Disease Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Dopamine Agonists

Table 3. Key Players of Levodopa

Table 4. Key Players of Glutamate Antagonist

Table 5. Key Players of Apomorphine

Table 6. Key Players of COMT Inhibitors Anticholinergics

Table 7. Key Players of MAO-B Inhibitors

Table 8. Key Players of Other Drugs

Table 9. Global Parkinson's Disease Treatments Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Parkinson's Disease Treatments Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Parkinson's Disease Treatments Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Parkinson's Disease Treatments Market Share by Region (2020-2025)

Table 13. Global Parkinson's Disease Treatments Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Parkinson's Disease Treatments Market Share by Region (2026-2031)

Table 15. Parkinson's Disease Treatments Market Trends

Table 16. Parkinson's Disease Treatments Market Drivers

Table 17. Parkinson's Disease Treatments Market Challenges

Table 18. Parkinson's Disease Treatments Market Restraints

Table 19. Global Parkinson's Disease Treatments Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Parkinson's Disease Treatments Market Share by Players (2020-2025)

Table 21. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2024)

Table 22. Ranking of Global Top Parkinson's Disease Treatments Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Parkinson's Disease Treatments Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Parkinson's Disease Treatments, Headquarters and Area Served

Table 25. Global Key Players of Parkinson's Disease Treatments, Product and Application

Table 26. Global Key Players of Parkinson's Disease Treatments, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Parkinson's Disease Treatments Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Parkinson's Disease Treatments Revenue Market Share by Type (2020-2025)

Table 30. Global Parkinson's Disease Treatments Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Parkinson's Disease Treatments Revenue Market Share by Type (2026-2031)

Table 32. Global Parkinson's Disease Treatments Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Parkinson's Disease Treatments Revenue Market Share by Application (2020-2025)

Table 34. Global Parkinson's Disease Treatments Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Parkinson's Disease Treatments Revenue Market Share by Application (2026-2031)

Table 36. North America Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Parkinson's Disease Treatments Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Parkinson's Disease Treatments Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Parkinson's Disease Treatments Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Parkinson's Disease Treatments Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Parkinson's Disease Treatments Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Parkinson's Disease Treatments Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Parkinson's Disease Treatments Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Parkinson's Disease Treatments Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Parkinson's Disease Treatments Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Parkinson's Disease Treatments Market Size by Country (2026-2031) & (US$ Million)

Table 51. GSK Company Details

Table 52. GSK Business Overview

Table 53. GSK Parkinson's Disease Treatments Product

Table 54. GSK Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 55. GSK Recent Development

Table 56. Merck Company Details

Table 57. Merck Business Overview

Table 58. Merck Parkinson's Disease Treatments Product

Table 59. Merck Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 60. Merck Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Parkinson's Disease Treatments Product

Table 64. Novartis Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 65. Novartis Recent Development

Table 66. Teva Company Details

Table 67. Teva Business Overview

Table 68. Teva Parkinson's Disease Treatments Product

Table 69. Teva Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 70. Teva Recent Development

Table 71. Boehringer Ingelheim Company Details

Table 72. Boehringer Ingelheim Business Overview

Table 73. Boehringer Ingelheim Parkinson's Disease Treatments Product

Table 74. Boehringer Ingelheim Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 75. Boehringer Ingelheim Recent Development

Table 76. Impax Company Details

Table 77. Impax Business Overview

Table 78. Impax Parkinson's Disease Treatments Product

Table 79. Impax Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 80. Impax Recent Development

Table 81. Abbvie Company Details

Table 82. Abbvie Business Overview

Table 83. Abbvie Parkinson's Disease Treatments Product

Table 84. Abbvie Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 85. Abbvie Recent Development

Table 86. Bausch Health Company Details

Table 87. Bausch Health Business Overview

Table 88. Bausch Health Parkinson's Disease Treatments Product

Table 89. Bausch Health Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 90. Bausch Health Recent Development

Table 91. Lundbeck Company Details

Table 92. Lundbeck Business Overview

Table 93. Lundbeck Parkinson's Disease Treatments Product

Table 94. Lundbeck Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 95. Lundbeck Recent Development

Table 96. Sun Pharma Company Details

Table 97. Sun Pharma Business Overview

Table 98. Sun Pharma Parkinson's Disease Treatments Product

Table 99. Sun Pharma Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 100. Sun Pharma Recent Development

Table 101. Wockhardt Company Details

Table 102. Wockhardt Business Overview

Table 103. Wockhardt Parkinson's Disease Treatments Product

Table 104. Wockhardt Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 105. Wockhardt Recent Development

Table 106. Acadia Company Details

Table 107. Acadia Business Overview

Table 108. Acadia Parkinson's Disease Treatments Product

Table 109. Acadia Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 110. Acadia Recent Development

Table 111. UCB Company Details

Table 112. UCB Business Overview

Table 113. UCB Parkinson's Disease Treatments Product

Table 114. UCB Revenue in Parkinson's Disease Treatments Business (2020-2025) & (US$ Million)

Table 115. UCB Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Parkinson's Disease Treatments Picture

Figure 2. Global Parkinson's Disease Treatments Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Parkinson's Disease Treatments Market Share by Type: 2024 VS 2031

Figure 4. Dopamine Agonists Features

Figure 5. Levodopa Features

Figure 6. Glutamate Antagonist Features

Figure 7. Apomorphine Features

Figure 8. COMT Inhibitors Anticholinergics Features

Figure 9. MAO-B Inhibitors Features

Figure 10. Other Drugs Features

Figure 11. Global Parkinson's Disease Treatments Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Parkinson's Disease Treatments Market Share by Application: 2024 VS 2031

Figure 13. Hospitals Case Studies

Figure 14. Healthcare Institutes Case Studies

Figure 15. Others Case Studies

Figure 16. Parkinson's Disease Treatments Report Years Considered

Figure 17. Global Parkinson's Disease Treatments Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Parkinson's Disease Treatments Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Parkinson's Disease Treatments Market Share by Region: 2024 VS 2031

Figure 20. Global Parkinson's Disease Treatments Market Share by Players in 2024

Figure 21. Global Top Parkinson's Disease Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Treatments as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Parkinson's Disease Treatments Revenue in 2024

Figure 23. North America Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Parkinson's Disease Treatments Market Share by Country (2020-2031)

Figure 25. United States Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Parkinson's Disease Treatments Market Share by Country (2020-2031)

Figure 29. Germany Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Parkinson's Disease Treatments Market Share by Region (2020-2031)

Figure 37. China Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Parkinson's Disease Treatments Market Share by Country (2020-2031)

Figure 45. Mexico Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Parkinson's Disease Treatments Market Share by Country (2020-2031)

Figure 49. Turkey Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Parkinson's Disease Treatments Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. GSK Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 55. Teva Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 56. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 57. Impax Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 58. Abbvie Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 59. Bausch Health Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 60. Lundbeck Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 61. Sun Pharma Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 62. Wockhardt Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 63. Acadia Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 64. UCB Revenue Growth Rate in Parkinson's Disease Treatments Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-4R20263

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Online Speech Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39V19943

Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Nerve Repair and Regeneration Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-10C17235

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Neurological Disease Model Chip Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-7M17348

Thu Nov 06 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Parkinson's Disease Treatments Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-4V2448

Global Parkinson's Disease Treatments Market Research Report 2025

FEATURED COMPANIES

Parkinson's Disease Treatments Market Size

Parkinson's Disease Treatments Market

Scope of Parkinson's Disease Treatments Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Parkinson's Disease Treatments Market report?

What are the Application segmentation covered in the Parkinson's Disease Treatments Market report?

What are the Type segmentation covered in the Parkinson's Disease Treatments Market report?

FEATURED COMPANIES

RELATED REPORTS